TY - JOUR
T1 - Effect of Pupil Dilation with Tropicamide on Retinal Vascular Caliber
AU - Frost, Shaun
AU - Gregory, Cynthia
AU - Robinson, Liam
AU - Yu, Shuang
AU - Xiao, Di
AU - Mehdizadeh, Maryam
AU - Burnham, Samantha
AU - Dehghani, Cirous
AU - Vignarajan, Janardhan
AU - Kanagasingam, Yogesan
AU - Schlaich, Markus P.
AU - Prentice, David
N1 - Funding Information:
SMF is supported by a National Health and Medical Research Council (NHMRC) Dementia Research Fellowship. MPS is supported by a National Health and Medical Research Council (NHMRC) Senior Research Fellowship.
Funding Information:
We thank all the participants who took part in this study and the clinicians who referred participants. The generous research support by the Royal Perth Hospital Medical Research Foundation (MRF) is also acknowledged.
Publisher Copyright:
© 2019, © 2019 Taylor & Francis Group, LLC.
PY - 2019/11/2
Y1 - 2019/11/2
N2 - Purpose: The retinal blood vessels reflect changes in the brain’s micro-circulation and these changes have been shown to correlate with the incidence of diseases such as stroke, heart disease and Alzheimer’s disease. Studies investigating the retinal vasculature routinely use pupil dilation with tropicamide to optimize image acquisition and quality. The aim of this study was to investigate the effects of tropicamide on retinal vascular parameters using retinal photography. Methods: The study was performed on 41 healthy young subjects of both sexes, using tropicamide to dilate only the right pupil, leaving the left as a control. Results: Pupil dilation with tropicamide resulted in reduced retinal vessel width measures based on standardized approaches, particularly reduced arteriolar caliber (p < .0005). However, closer investigation of the images revealed reduced fundus image magnification in the post-tropicamide images, based on reduced optic nerve head diameter (p < .0005) and longitudinal analysis with image registration and affine transformation (p < .0001). No change in vessel width parameters was observed after adjustment for image magnification. Conclusion: These results suggest that tropicamide does not change the width of the retinal vessels, however width parameters as measured by standard approaches may be reduced due to image magnification changes resulting from cycloplegia. In this study, improved optic nerve head segmentation for image scale conversion removed the magnification error. With this correction, the tropicamide intervention had no effect on vessel width parameters in young healthy people and could be utilized in future without affecting the results of retinal vascular analysis.
AB - Purpose: The retinal blood vessels reflect changes in the brain’s micro-circulation and these changes have been shown to correlate with the incidence of diseases such as stroke, heart disease and Alzheimer’s disease. Studies investigating the retinal vasculature routinely use pupil dilation with tropicamide to optimize image acquisition and quality. The aim of this study was to investigate the effects of tropicamide on retinal vascular parameters using retinal photography. Methods: The study was performed on 41 healthy young subjects of both sexes, using tropicamide to dilate only the right pupil, leaving the left as a control. Results: Pupil dilation with tropicamide resulted in reduced retinal vessel width measures based on standardized approaches, particularly reduced arteriolar caliber (p < .0005). However, closer investigation of the images revealed reduced fundus image magnification in the post-tropicamide images, based on reduced optic nerve head diameter (p < .0005) and longitudinal analysis with image registration and affine transformation (p < .0001). No change in vessel width parameters was observed after adjustment for image magnification. Conclusion: These results suggest that tropicamide does not change the width of the retinal vessels, however width parameters as measured by standard approaches may be reduced due to image magnification changes resulting from cycloplegia. In this study, improved optic nerve head segmentation for image scale conversion removed the magnification error. With this correction, the tropicamide intervention had no effect on vessel width parameters in young healthy people and could be utilized in future without affecting the results of retinal vascular analysis.
KW - biomarkers
KW - eye
KW - Retina
KW - vasculature
KW - Humans
KW - Male
KW - Tropicamide/pharmacology
KW - Ophthalmic Solutions/pharmacology
KW - Mydriatics/pharmacology
KW - Pupil/drug effects
KW - Young Adult
KW - Adult
KW - Female
KW - Retinal Vessels/drug effects
UR - http://www.scopus.com/inward/record.url?scp=85068622665&partnerID=8YFLogxK
U2 - 10.1080/09286586.2019.1639198
DO - 10.1080/09286586.2019.1639198
M3 - Article
C2 - 31267797
AN - SCOPUS:85068622665
SN - 0928-6586
VL - 26
SP - 400
EP - 407
JO - Ophthalmic Epidemiology
JF - Ophthalmic Epidemiology
IS - 6
ER -